APA (7th ed.) Citation

Friedman, S. M., Xu, Y., Sherman, S., Kuznik, A., Mojebi, A., Keeping, S., . . . Patel, N. (2026). Correction: Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. Ophthalmology & Therapy, 15(5), 1865. https://doi.org/10.1007/s40123-026-01377-2

Chicago Style (17th ed.) Citation

Friedman, Scott M., Yingxin Xu, Steven Sherman, Andreas Kuznik, Ali Mojebi, Sam Keeping, Keith Chan, Theodore Leng, and Nimesh Patel. "Correction: Aflibercept 8 Mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials." Ophthalmology & Therapy 15, no. 5 (2026): 1865. https://doi.org/10.1007/s40123-026-01377-2.

MLA (9th ed.) Citation

Friedman, Scott M., et al. "Correction: Aflibercept 8 Mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials." Ophthalmology & Therapy, vol. 15, no. 5, 2026, p. 1865, https://doi.org/10.1007/s40123-026-01377-2.